O.N. Shestovets
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
O.N. Shestovets has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- E. P. Naumenko
The Republican Research Center for Radiation Medicine and Human Ecology
1 shared publication - L. E. Korotaeva
Republican Scientific and Practical Center for Radiation Medicine and Human Ecology
1 shared publication - Tatsiana V. Mokhort
Belarusian State Medical University
1 shared publication - Valentina K. Bayrasheva
Institute of Endocrinology, Almazov National Medical Research Centre, Saint Petersburg, Russia
1 shared publication - Volha Vasilkova
Gomel State Medical University
1 shared publication - Ya. A. Borovets
Gomel State Medical University
1 shared publication
Latest Publications
- Open Access
- 1 January 2020
- Published by Scientia Publishing House LTD in Juvenis scientia
- Vol. 6 (2) , 36-43
EVALUATION OF THE LEVELS OF FIBROBLAST GROWTH FACTOR (FGF-23) AND INFLAMMATION MARKERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE
Recently, inflammatory and regulatory mechanisms that are involved in the onset and progression of angiopathies in diabetes mellitus (DM), including diabetic kidney disease (DKD), have been studied. In this study, we assessed the levels of fibroblast growth factor-23 (FGF-23) and inflammatory markers in patients with type 2 DM and different stages of chronic kidney disease (CKD). We investigated 64 patients with type 2 DM aged 34-84 years. The results showed significant changes in the levels of FGF-23, tumour necrosis factor alpha (TNF-alpha), C-reactive protein (CRP), high-sensitivity C-reactive protein (hsCRP), and interleukin-6 (IL-6) with the progression of CKD in patients with type 2 diabetes. Multiple regression analysis demonstrated the presence of an independent interconnection between serum levels of FGF-23 and creatinine.
- 1 January 2020
- Published by Scientia Publishing House LTD in Juvenis scientia
- Vol. 6 (2) , 36-43
Open AccessEVALUATION OF THE LEVELS OF FIBROBLAST GROWTH FACTOR (FGF-23) AND INFLAMMATION MARKERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE
Recently, inflammatory and regulatory mechanisms that are involved in the onset and progression of angiopathies in diabetes mellitus (DM), including diabetic kidney disease (DKD), have been studied. In this study, we assessed the levels of fibroblast growth factor-23 (FGF-23) and inflammatory markers in patients with type 2 DM and different stages of chronic kidney disease (CKD). We investigated 64 patients with type 2 DM aged 34-84 years. The results showed significant changes in the levels of FGF-23, tumour necrosis factor alpha (TNF-alpha), C-reactive protein (CRP), high-sensitivity C-reactive protein (hsCRP), and interleukin-6 (IL-6) with the progression of CKD in patients with type 2 diabetes. Multiple regression analysis demonstrated the presence of an independent interconnection between serum levels of FGF-23 and creatinine.